Once the need for drug therapy has been determined, the JNC-6 report provides three pathways for the choice of therapy: for uncomplicated patients, a diuretic or β-blocker; for patients with diabetic nephropathy, isolated systolic hypertension, congestive heart failure or systolic dysfunction after myocardial infarction, specific drugs are compellingly indicated; for other conditions, certain drugs that provide favorable effects are recommended. Whatever drug is chosen, long-acting preparations that provide 24-h coverage with one daily dose are recommended.
|Original language||English (US)|
|Number of pages||7|
|Journal||Drugs of Today|
|Publication status||Published - 1998|
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology (medical)